openPR Logo
Press release

Pain Management Therapeutics Market is Expected to Exceed US$ 83 Billion by 2024

New York, May 11: Market Research Engine has published a new report titled as “Pain Management Therapeutics Market by Therapeutics Analysis (Antidepressants, Anesthetics, Anticonvulsants, Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic); by Indication Analysis (Migraine, Cancer Pain, Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Post-operative Pain) - Global Industry Analysis and Forecast 2016 - 2024”

How Big is The Pain Management Therapeutics Market?

The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/pain-management-therapeutics-market

Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients every year.


The major driving factors of pain management therapeutics market are as follows:

Approving health care reforms and regulatory scenario
Increasing approval of pain management therapeutics between end users
Increasing in geriatric population with high risk of different diseases
Growing frequency of chronic pain disorders

The restraining factors of pain management therapeutics market are as follows:

Enduring pain relief from medical devices, alternative therapies and surgical procedures
Prescription drug exploitation
Exclusive rights expiry of entry of generics and key drugs

The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeutics market covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for pain management therapeutics and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2024.

3) Identifications of new market opportunities and targeted promotional plans for pain management therapeutics.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for pain management therapeutics with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide buyers with a snapshot of the industry’s most influential players.

The Pain management therapeutics Market has been segmented as below:

By Therapeutics Analysis

Antimigraine agents
Non steroidal anti inflammatory drugs
Anesthetics
Antidepressants
Anticonvulsants
Opioids
Tramadol
Hydrocodones
Oxycodaones
Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine)
Other non narcotic analgesic

By Indication Analysis

Cancer pain
Post operative pain
Migraine
Arthritic pain
Chronic back pain
Fibromyalgia
Neuropathic pain

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all pain management therapeutics market globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of pain management therapeutics data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pain Management Therapeutics Market is Expected to Exceed US$ 83 Billion by 2024 here

News-ID: 533543 • Views: 331

More Releases from Market Research Engine Report

3D Printing Materials Market is Expected to Exceed USD 1400 Million by 2020
The 3 D Printing Materials Market is segmented based on material type, form and application. The 3 D Printing Materials Market is segmented based on material type as Plastics, Metals, Ceramics, Others. The 3 D Printing Materials Market is segmented based on form as Filament, Powder, Liquid. The 3 D Printing Materials Market is segmented based on application as Aerospace & defense, Medical & dental, Automotive, Consumer Goods,
Titanium Dioxide Market is Expected to Reach US$ 21 Billion by 2021
The global titanium dioxide market by application is segmented as paints & coatings, pulp & paper, plastics, cosmetics and other applications. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/titanium-dioxide-market How Big is the Global Titanium Dioxide Market? Global titanium dioxide market was accounted USD 15.5 billion in 2015. The revenue of this market is anticipated to increase
IoT Healthcare Market in North America is Expected to Grow at CAGR of 43% by 202 …
The IoT healthcare market is divided into technologies and services. The technologies segment is again analyzed by network technologies and applications technologies. The network technologies are further segmented to short range technologies and long-range technologies which are equally vital top form a connected ecosystem of healthcare. The service market is analyzed by consulting, integration and maintenance. The solution segment contributes to a majority part of the market. Browse Full Report
Nonalcoholic Steatohepatitis (NASH) Market is Expected to Cross US$ 20.0 Billion …
The Nonalcoholic Steatohepatitis market is segmented on the lines of its Therapeutics such as GFT505, Obeticholic Acid (INT-747) Simtuzumab and Liraglutide (Victoza)Vitamin EPioglitazonePlacebo. The Nonalcoholic Steatohepatitis market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Browse Full Report @: https://www.marketresearchengine.com/reportdetails/non-alcoholic-steatohepatitis-nash-market How Big is the Global Nonalcoholic Steatohepatitis (NASH) Market? Global Non-Alcoholic Steatohepatitis (NASH) market is expected to cross US$ 20.0 Billion by

All 5 Releases